CNBX Pharmaceuticals Statistics
Total Valuation
CNBX has a market cap or net worth of 17,837. The enterprise value is 1.37 million.
| Market Cap | 17,837 |
| Enterprise Value | 1.37M |
Important Dates
The last earnings date was Monday, April 14, 2025.
| Earnings Date | Apr 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CNBX has 4.20 million shares outstanding. The number of shares has increased by 39.94% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 4.20M |
| Shares Change (YoY) | +39.94% |
| Shares Change (QoQ) | +3.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 8.68% |
| Float | 3.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.64 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.26 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -178.49% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 11.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -295,356 |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.94% in the last 52 weeks. The beta is 0.61, so CNBX's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -64.94% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 33.92 |
| Average Volume (20 Days) | 497,526 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.49 |
Income Statement
| Revenue | n/a |
| Gross Profit | 17,570 |
| Operating Income | -306,392 |
| Pretax Income | -295,356 |
| Net Income | -295,356 |
| EBITDA | -270,232 |
| EBIT | -306,392 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 45,675 in cash and 1.40 million in debt, giving a net cash position of -1.35 million or -0.32 per share.
| Cash & Cash Equivalents | 45,675 |
| Total Debt | 1.40M |
| Net Cash | -1.35M |
| Net Cash Per Share | -0.32 |
| Equity (Book Value) | -2.57M |
| Book Value Per Share | -0.08 |
| Working Capital | -2.57M |
Cash Flow
| Operating Cash Flow | -138,766 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.94% |
| Shareholder Yield | -39.94% |
| Earnings Yield | -1,655.86% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on May 12, 2022. It was a reverse split with a ratio of 0.0083333.
| Last Split Date | May 12, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0083333 |
Scores
CNBX has an Altman Z-Score of -773.28. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -773.28 |
| Piotroski F-Score | n/a |